Should I take protein powder on Mounjaro
Innovent receives FDA Approval for IND application of oral GLP-1R agonist IBI3032 owenhaskins Aug 6, 2025 2 min read Innovent Biologics has announced the FDA has approved the investigational new drug (IND) application to initiate a Phase 1 clinical trial of IBI3032, the company's novel oral GLP-1R agonist
Experts recommend precision nutrition strategies: Smaller, nutrient-dense meals rich in high-quality protein Micronutrient support for vitamins B12, D, folate, magnesium and iron Hydration solutions to counter reduced thirst signals Fiber and probiotics to support gut health GLP-1 therapies are revolutionizing obesity and diabetes care, but they also reshape physiology in ways that demand attention
This additional mechanism helps increase insulin sensitivity even further and enhances fat metabolism, making tirzepatide-plus particularly effective for people with type 2 diabetes and those with more significant weight loss goals
Zhang Y, Zhou J, Ye Q, et al
The reverse can also be true (drop in capacity while internal resistance remains low)
